Genomics BioSci & Tech. Co.,Ltd.
TWO: 4195.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Rita Wu
- Employees
- 120
- Headquarters
- New Taipei City, Taiwan
- IPO year
- 2013
- Market cap
- NT$2.1B
- Website
- https://www.genomics.com.tw
Loading 4195…
Loading profile data…Frequently asked questions about 4195
What does Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) do?
Genomics BioSci & Tech. Co.,Ltd. operates as a genome sequencing company. It offers regular DNA, complex sequence, and TAF certificated sequencing services, as well as free sequencing primer and primer walking services; peptide, gene, and oligo synthesis services; and sample preparation, gene expression analysis, genotyping analysis, DNA methyla...
Where does 4195.TWO trade?
Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) trades on the Taipei Exchange.
What sector is 4195.TWO in?
Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Genomics BioSci & Tech. Co.,Ltd.?
Rita Wu is the chief executive officer of Genomics BioSci & Tech. Co.,Ltd. (4195.TWO).
Where is Genomics BioSci & Tech. Co.,Ltd. headquartered?
Genomics BioSci & Tech. Co.,Ltd. is headquartered in Taiwan.
Does 4195.TWO pay a dividend?
Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4195.TWO go public?
Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) completed its initial public offering in 2013.